Nanobiotix S.A.'s (EPA:NANO) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 29
French (CAC) Biotech Industry Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies27
- 7D-3.2%
- 3M-11.3%
- 1Y-30.1%
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 3.0%, driven by ABIVAX Société Anonyme declining 8.0%. On the other hand DBV Technologies is actually up 21%. However, the industry is down 30% over the past year. Earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | €2.9b | €511.7m | -€566,747,247.86 | 29.2x | -5.1x | 5.7x |
| Sun, 23 Jun 2024 | €2.9b | €514.4m | -€569,641,165.19 | 26.4x | -5.1x | 5.7x |
| Tue, 21 May 2024 | €3.3b | €502.4m | -€592,669,315.06 | 28x | -5.6x | 6.6x |
| Thu, 18 Apr 2024 | €3.2b | €515.6m | -€629,015,737.81 | 27.6x | -5.1x | 6.2x |
| Sat, 16 Mar 2024 | €3.1b | €567.9m | -€645,920,503.60 | 21.2x | -4.8x | 5.5x |
| Mon, 12 Feb 2024 | €3.0b | €558.9m | -€674,772,026.21 | 22.1x | -4.4x | 5.4x |
| Wed, 10 Jan 2024 | €3.2b | €594.3m | -€683,479,140.00 | 23.3x | -4.7x | 5.4x |
| Fri, 08 Dec 2023 | €3.2b | €594.7m | -€685,565,196.00 | 22x | -4.6x | 5.3x |
| Sun, 05 Nov 2023 | €3.3b | €803.4m | -€564,493,061.00 | 21.2x | -5.9x | 4.1x |
| Tue, 03 Oct 2023 | €3.3b | €831.5m | -€577,342,820.00 | 14.3x | -5.8x | 4x |
| Thu, 31 Aug 2023 | €3.8b | €817.9m | -€725,436,656.00 | 23.9x | -5.3x | 4.7x |
| Sat, 29 Jul 2023 | €3.8b | €817.6m | -€735,033,986.00 | 24.7x | -5.1x | 4.6x |
| Mon, 26 Jun 2023 | €3.9b | €820.0m | -€744,113,037.00 | 25.4x | -5.2x | 4.7x |
| Wed, 24 May 2023 | €3.8b | €829.3m | -€769,042,507.00 | 26.1x | -4.9x | 4.6x |
| Fri, 21 Apr 2023 | €3.5b | €877.9m | -€737,347,795.00 | 31.2x | -4.8x | 4x |
| Sun, 19 Mar 2023 | €3.3b | €1.0b | -€480,608,887.00 | 9.5x | -6.8x | 3.2x |
| Tue, 14 Feb 2023 | €3.7b | €1.0b | -€456,698,143.00 | 11.4x | -8x | 3.5x |
| Thu, 12 Jan 2023 | €3.8b | €1.0b | -€454,250,269.00 | 12.4x | -8.3x | 3.6x |
| Sat, 10 Dec 2022 | €3.5b | €1.0b | -€457,611,814.00 | 12.7x | -7.6x | 3.3x |
| Mon, 07 Nov 2022 | €3.5b | €904.8m | -€706,532,567.00 | 16.4x | -5x | 3.9x |
| Wed, 05 Oct 2022 | €3.4b | €923.4m | -€674,887,249.00 | 30.8x | -5x | 3.7x |
| Fri, 02 Sep 2022 | €4.1b | €929.9m | -€752,549,737.00 | 111.8x | -5.5x | 4.4x |
| Sun, 31 Jul 2022 | €4.3b | €983.0m | -€689,206,520.00 | 120.9x | -6.3x | 4.4x |
| Tue, 28 Jun 2022 | €4.7b | €992.3m | -€691,769,875.00 | 124.8x | -6.8x | 4.7x |
| Thu, 26 May 2022 | €4.5b | €990.2m | -€689,836,496.00 | 134x | -6.6x | 4.6x |
| Sat, 23 Apr 2022 | €4.9b | €1.2b | -€491,042,009.00 | 2.8x | -10.1x | 4.1x |
| Mon, 21 Mar 2022 | €5.5b | €950.2m | -€648,336,889.00 | 17.7x | -8.4x | 5.7x |
| Wed, 16 Feb 2022 | €5.3b | €929.7m | -€676,245,490.00 | 2.9x | -7.9x | 5.7x |
| Fri, 14 Jan 2022 | €6.1b | €931.0m | -€675,891,726.00 | 3.1x | -9.1x | 6.6x |
| Sun, 12 Dec 2021 | €6.8b | €923.7m | -€681,215,191.00 | 2.7x | -10x | 7.4x |
| Tue, 09 Nov 2021 | €6.6b | €924.4m | -€678,522,393.00 | 2.3x | -9.8x | 7.2x |
| Thu, 07 Oct 2021 | €6.6b | €898.8m | -€717,233,949.00 | 2.8x | -9.2x | 7.3x |
| Sat, 04 Sep 2021 | €7.8b | €899.6m | -€600,532,159.12 | 2.8x | -13x | 8.6x |
| Mon, 02 Aug 2021 | €6.5b | €899.6m | -€600,532,159.12 | 2.7x | -10.9x | 7.3x |
Price to Earnings Ratio
-10.9x
Current Industry PE
- Investors are optimistic on the French Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.1x is lower than the industry's current PS ratio of 5.7x.
Past Earnings Growth
- Losses for companies in the Biotechnology industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have declined 17% per year.
- This means that the cost of doing business could be reducing since sales have declined but losses haven't fallen much further.
Industry Comparison
How does French Biotech compare with similar industries?
| FR Market | -2.35% | |
| Healthcare | 2.03% | |
| Biotech | -3.23% | |
| Biotech | -3.23% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DBV DBV Technologies | €0.97 | 21.3% +€16.4m | -68.7% | PS6.8x | |
| ALTAO Aton | €0.012 | 23.0% +€5.5m | -78.4% | n/a | |
| IPH Innate Pharma | €2.10 | 2.4% +€4.0m | -25.0% | PS2.8x | |
| ALERS Eurobio Scientific Société anonyme | €17.00 | 1.9% +€3.2m | 14.1% | PE35.3x | |
| SIGHT GenSight Biologics | €0.31 | 8.3% +€2.5m | -55.9% | PS11x |
